SF - Thanks for the links. Novo was my first pick for partnership at the 12 month mark of our BoM trial. Interesting that the cardio guy is coming over from Astra. He should know full well that RVX-208 worked better with Astra's drug than PFE's. I'm definitely curious to see if this will affect us over the coming months. Nothing could be better for us than one company not wanting another company to have a competitive product.

I sincerely hope the bidding has already begun.

tada